Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't ...
Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust, working with the National Institute of Allergy and Infectious Diseases (NIAID) and Genentech, have ...
Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease and often don't ...
Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...
Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...
Alopecia areata and asthma share inflammatory pathways, with IL-33 playing a significant mediating role in their association. Mendelian randomization analysis revealed a strong link between asthma and ...
Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...
One in ten school-aged children in Australia have a current diagnosis of asthma. Every year, there are around 40,000 asthma hospitalizations and over 40 per cent of these are in children aged younger ...
PHILADELPHIA -- Asthma is an enormous public health problem that continues to grow larger, in part because scientists don't fully understand how it is caused. Existing therapies don't cure the disease ...
New insights have been gained into how asthma may be caused, by identifying three distinct groups of asthma patients characterized by the activity of different genes in an individual’s airways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback